Recruiting Glaucoma Studies in Oklahoma City
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant...
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucoma gel stent is when implanted using the ab interno ...
About Glaucoma Clinical Trials in Oklahoma City
Glaucoma is a group of eye conditions that damage the optic nerve, often due to abnormally high eye pressure, and is a leading cause of irreversible blindness. Open-angle glaucoma is the most common form. Treatment includes eye drops, laser treatment, and surgery to lower eye pressure.
There are currently 2 glaucoma clinical trials recruiting participants in Oklahoma City, OKLAHOMA. These studies are seeking a combined 740 participants. Research is being sponsored by Glaukos Corporation, AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.
Glaucoma Clinical Trials in Oklahoma City — FAQ
Are there glaucoma clinical trials in Oklahoma City?
Yes, there are 2 glaucoma clinical trials currently recruiting in Oklahoma City, OKLAHOMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Oklahoma City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you about next steps.
Are clinical trials in Oklahoma City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oklahoma City studies also compensate for your time and travel.
What glaucoma treatments are being tested?
The 2 active trials in Oklahoma City are testing new therapies including novel drugs, biologics, and treatment approaches for glaucoma.
Data updated March 2, 2026 from ClinicalTrials.gov